{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:04:17Z","timestamp":1780434257248,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0011851","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000}}],"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0108080"],"award-info":[{"award-number":["JP21fk0108080"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22wm0325002"],"award-info":[{"award-number":["22wm0325002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["2017045212"],"award-info":[{"award-number":["2017045212"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["2021181927"],"award-info":[{"award-number":["2021181927"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"publisher","award":["46-3"],"award-info":[{"award-number":["46-3"]}],"id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K06016"],"award-info":[{"award-number":["JP22K06016"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Nipah virus (NiV) is a highly pathogenic zoonotic virus that causes severe encephalitis and respiratory diseases and has a high mortality rate in humans (&gt;40%). Epidemiological studies on various fruit bat species, which are natural reservoirs of the virus, have shown that NiV is widely distributed throughout Southeast Asia. Therefore, there is an urgent need to develop effective NiV vaccines. In this study, we generated recombinant vaccinia viruses expressing the NiV glycoprotein (G) or fusion (F) protein using the LC16m8 strain, and examined their antigenicity and ability to induce immunity. Neutralizing antibodies against NiV were successfully induced in hamsters inoculated with LC16m8 expressing NiV G or F, and the antibody titers were higher than those induced by other vaccinia virus vectors previously reported to prevent lethal NiV infection. These findings indicate that the LC16m8-based vaccine format has superior features as a proliferative vaccine compared with other poxvirus-based vaccines. Moreover, the data collected over the course of antibody elevation during three rounds of vaccination in hamsters provide an important basis for the clinical use of vaccinia virus-based vaccines against NiV disease.<\/jats:p>\n<jats:p><jats:bold>Trial Registration<\/jats:bold>: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05398796\" xlink:type=\"simple\">NCT05398796<\/jats:ext-link>.<\/jats:p>","DOI":"10.1371\/journal.pntd.0011851","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T18:45:48Z","timestamp":1702665948000},"page":"e0011851","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3359-7192","authenticated-orcid":true,"given":"Shumpei","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kurosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuetsu","family":"Fukushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nishisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shimojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"issue":"7","key":"pntd.0011851.ref001","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00705-019-04247-4","article-title":"Taxonomy of the order Mononegavirales: update 2019","volume":"164","author":"GK Amarasinghe","year":"2019","journal-title":"Arch Virol"},{"key":"pntd.0011851.ref002","first-page":"41","article-title":"Molecular virology of the henipaviruses","volume":"359","author":"PA Rota","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"pntd.0011851.ref003","article-title":"Nipah Virus Infection","volume":"56","author":"BSP Ang","year":"2018","journal-title":"J Clin Microbiol"},{"key":"pntd.0011851.ref004","first-page":"25","article-title":"Epidemiology of henipavirus disease in humans","volume":"359","author":"SP Luby","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"pntd.0011851.ref005","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3201\/eid1307.061128","article-title":"Person-to-person transmission of Nipah virus in a Bangladeshi community","volume":"13","author":"ES Gurley","year":"2007","journal-title":"Emerging infectious diseases"},{"issue":"11","key":"pntd.0011851.ref006","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/647951","article-title":"Transmission of human infection with Nipah virus","volume":"49","author":"SP Luby","year":"2009","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"pntd.0011851.ref007","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3201\/eid1803.111121","article-title":"Serologic evidence of nipah virus infection in bats, Vietnam","volume":"18","author":"F Hasebe","year":"2012","journal-title":"Emerging infectious diseases"},{"issue":"7","key":"pntd.0011851.ref008","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3201\/eid1107.041350","article-title":"Nipah virus in Lyle\u2019s flying foxes, Cambodia","volume":"11","author":"JM Reynes","year":"2005","journal-title":"Emerging infectious diseases"},{"issue":"4","key":"pntd.0011851.ref009","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3201\/eid1204.051181","article-title":"Henipavirus in Pteropus vampyrus bats, Indonesia","volume":"12","author":"I Sendow","year":"2006","journal-title":"Emerging infectious diseases"},{"key":"pntd.0011851.ref010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12985-016-0510-x","article-title":"Molecular characterization of Nipah virus from Pteropus hypomelanus in Southern Thailand","volume":"13","author":"S Wacharapluesadee","year":"2016","journal-title":"Virology journal"},{"key":"pntd.0011851.ref011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"MS Mehand","year":"2018","journal-title":"Antiviral research"},{"issue":"26","key":"pntd.0011851.ref012","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.vaccine.2015.12.075","article-title":"Status of vaccine research and development of vaccines for Nipah virus","volume":"34","author":"BA Satterfield","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"pntd.0011851.ref013","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/JVI.78.2.834-840.2004","article-title":"Nipah virus: vaccination and passive protection studies in a hamster model","volume":"78","author":"V Guillaume","year":"2004","journal-title":"Journal of virology"},{"key":"pntd.0011851.ref014","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1038\/npjvaccines.2016.3","article-title":"Protection from Hendra virus infection with Canarypox recombinant vaccine","volume":"1","author":"V Guillaume-Vasselin","year":"2016","journal-title":"NPJ Vaccines"},{"issue":"21","key":"pntd.0011851.ref015","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January-October 2003","volume":"294","author":"CG Casey","year":"2005","journal-title":"JAMA"},{"issue":"24","key":"pntd.0011851.ref016","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel","volume":"289","author":"JS Halsell","year":"2003","journal-title":"JAMA"},{"issue":"Suppl 3","key":"pntd.0011851.ref017","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/524749","article-title":"Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board","volume":"46","author":"J Neff","year":"2008","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"21","key":"pntd.0011851.ref018","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1001\/jama.294.21.2744","article-title":"Neurologic adverse events associated with smallpox vaccination in the United States, 2002\u20132004","volume":"294","author":"JJ Sejvar","year":"2005","journal-title":"JAMA"},{"issue":"10","key":"pntd.0011851.ref019","doi-asserted-by":"crossref","first-page":"257","DOI":"10.15585\/mmwr.mm6510a2","article-title":"Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses\u2014Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015","volume":"65","author":"BW Petersen","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"pntd.0011851.ref020","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/v7041726","article-title":"The evolution of poxvirus vaccines","volume":"7","author":"L Sanchez-Sampedro","year":"2015","journal-title":"Viruses"},{"issue":"16","key":"pntd.0011851.ref021","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"IM Belyakov","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6979","key":"pntd.0011851.ref022","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"PL Earl","year":"2004","journal-title":"Nature"},{"issue":"9","key":"pntd.0011851.ref023","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults","volume":"204","author":"JS Kennedy","year":"2011","journal-title":"J Infect Dis"},{"issue":"11","key":"pntd.0011851.ref024","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1128\/JVI.02642-05","article-title":"LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox","volume":"80","author":"M Saijo","year":"2006","journal-title":"Journal of virology"},{"issue":"13","key":"pntd.0011851.ref025","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"LS Wyatt","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"pntd.0011851.ref026","first-page":"305","article-title":"Vaccines against monkeypox","volume":"160","author":"J Reina","year":"2023","journal-title":"Med Clin (Engl Ed)"},{"issue":"47\u201348","key":"pntd.0011851.ref027","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"J Kenner","year":"2006","journal-title":"Vaccine"},{"issue":"18","key":"pntd.0011851.ref028","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1128\/JVI.79.18.11873-11891.2005","article-title":"An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection","volume":"79","author":"S Morikawa","year":"2005","journal-title":"Journal of virology"},{"issue":"Pt 5","key":"pntd.0011851.ref029","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"TJ Blanchard","year":"1998","journal-title":"J Gen Virol"},{"issue":"2","key":"pntd.0011851.ref030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"MW Carroll","year":"1997","journal-title":"Virology"},{"issue":"Pt 2","key":"pntd.0011851.ref031","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"I Drexler","year":"1998","journal-title":"J Gen Virol"},{"issue":"45","key":"pntd.0011851.ref032","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1016\/j.vaccine.2015.09.067","article-title":"Freeze-dried live attenuated smallpox vaccine prepared in cell culture \"LC16-KAKETSUKEN\": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice","volume":"33","author":"Y Nishiyama","year":"2015","journal-title":"Vaccine"},{"issue":"10","key":"pntd.0011851.ref033","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"T Saito","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"pntd.0011851.ref034","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"J Tartaglia","year":"1992","journal-title":"Virology"},{"key":"pntd.0011851.ref035","doi-asserted-by":"crossref","first-page":"845969","DOI":"10.3389\/fimmu.2022.845969","article-title":"MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters","volume":"13","author":"R Boudewijns","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"pntd.0011851.ref036","doi-asserted-by":"crossref","first-page":"e0156637","DOI":"10.1371\/journal.pone.0156637","article-title":"Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses","volume":"11","author":"SD Dowall","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0011851.ref037","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.vaccine.2006.08.039","article-title":"SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus","volume":"25","author":"M Kitabatake","year":"2007","journal-title":"Vaccine"},{"key":"pntd.0011851.ref038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coi.2021.03.008","article-title":"Ebola virus disease: current vaccine solutions","volume":"71","author":"O Tomori","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"pntd.0011851.ref039","doi-asserted-by":"crossref","first-page":"e1008859","DOI":"10.1371\/journal.ppat.1008859","article-title":"A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome","volume":"17","author":"T Yoshikawa","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"pntd.0011851.ref040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12985-020-01425-8","article-title":"Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories","volume":"17","author":"S Watanabe","year":"2020","journal-title":"Virology journal"},{"issue":"3","key":"pntd.0011851.ref041","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7883\/yoken.JJID.2017.458","article-title":"A Novel System for Constructing a Recombinant Highly-Attenuated Vaccinia Virus Strain (LC16m8) Expressing Foreign Genes and Its Application for the Generation of LC16m8-Based Vaccines against Herpes Simplex Virus 2","volume":"71","author":"N Omura","year":"2018","journal-title":"Jpn J Infect Dis"},{"issue":"8","key":"pntd.0011851.ref042","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00705-012-1338-3","article-title":"Antigen capture ELISA system for henipaviruses using polyclonal antibodies obtained by DNA immunization","volume":"157","author":"Y Kaku","year":"2012","journal-title":"Arch Virol"},{"key":"pntd.0011851.ref043","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1743-422X-7-312","article-title":"A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system","volume":"7","author":"D Khetawat","year":"2010","journal-title":"Virology journal"},{"issue":"2","key":"pntd.0011851.ref044","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"H Niwa","year":"1991","journal-title":"Gene"},{"key":"pntd.0011851.ref045","first-page":"153","article-title":"Animal challenge models of henipavirus infection and pathogenesis","volume":"359","author":"TW Geisbert","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"pntd.0011851.ref046","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"G. K\u00e4rber","year":"1931","journal-title":"Naunyn-Schmiedebergs Archiv f\u00fcr experimentelle pathologie und pharmakologie"},{"issue":"1","key":"pntd.0011851.ref047","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jviromet.2011.11.003","article-title":"Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase","volume":"179","author":"Y Kaku","year":"2012","journal-title":"Journal of virological methods"},{"issue":"1","key":"pntd.0011851.ref048","doi-asserted-by":"crossref","first-page":"e0152622","DOI":"10.1128\/mbio.01526-22","article-title":"Molecular Mechanisms of Poxvirus Evolution","volume":"14","author":"G Brennan","year":"2023","journal-title":"mBio"},{"issue":"4","key":"pntd.0011851.ref049","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/vaccines2040755","article-title":"Vaccinia Virus LC16m8\u0394 as a Vaccine Vector for Clinical Applications","volume":"2","author":"M Kidokoro","year":"2014","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"pntd.0011851.ref050","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"M Kidokoro","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"pntd.0011851.ref051","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"G Antoine","year":"1998","journal-title":"Virology"},{"issue":"Pt 5","key":"pntd.0011851.ref052","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"H Meyer","year":"1991","journal-title":"J Gen Virol"},{"issue":"12","key":"pntd.0011851.ref053","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.02108-05","article-title":"Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene","volume":"80","author":"JL Najera","year":"2006","journal-title":"Journal of virology"},{"issue":"45","key":"pntd.0011851.ref054","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1016\/j.vaccine.2015.07.076","article-title":"Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice","volume":"33","author":"H Yokote","year":"2015","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011851","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T18:33:52Z","timestamp":1703874832000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011851"}},"subtitle":[],"editor":[{"given":"Prashant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0011851","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0011851","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}